We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Inks Deal With Vertex to Develop New Pain Drug
GSK Inks Deal With Vertex to Develop New Pain Drug
December 13, 2005
GlaxoSmithKline (GSK) is partnering with Vertex Pharmaceuticals to commercialize VX-409, Vertex’s investigational pain drug.